Finance Watch: Turnstone Biologics Launches 14th Biopharma IPO Of 2023
Upsized Offering Prices At Low End Of Proposed Range
Turnstone’s initial public offering comes just one week after Apogee and Sagimet launched US IPOs. Also, Westlake Village BioPartners raised $450m for its third venture capital fund and argenx grossed $1.27bn in a post-Phase III follow-on offering.
